Diverse pathogen and toxin surface antigens

Diverse pathogen and toxin surface antigens represent a heterogeneous group of molecules found on the exterior of infectious agents (viruses, bacteria, fungi, parasites) and biological toxins. These antigens, which include proteins, glycoproteins, polysaccharides, and lipids, are essential for the pathogen's ability to infect host cells, evade immune detection, or exert toxic effects (Janeway's Immunobiology, 2017). They serve as the primary recognition sites for the host's adaptive immune system and are the focal points for vaccine development and passive immunotherapy using monoclonal antibodies (NIH, 2023). Because this term encompasses a vast array of distinct molecular entities across different species, it is considered a functional category rather than a single, specific therapeutic target. Drugs targeting these antigens typically work by neutralizing the pathogen's infectivity or the toxin's activity, or by marking them for destruction by the immune system (FDA, 2023). For example, monoclonal antibodies can bind to viral spike proteins to prevent entry into host cells or bind to bacterial toxins to inhibit their enzymatic activity. However, the high rate of mutation in many pathogens can lead to antigenic drift, necessitating the development of broad-spectrum or multi-target therapies.

Other names

Pathogen surface antigensMicrobial surface antigensToxin surface antigensSurface epitopesPathogen-associated molecular patterns (PAMPs)

Drugs targeting these antigens primarily function through neutralization, where the therapeutic agent binds to the surface antigen to prevent the pathogen from interacting with host cell receptors or to block the active site of a toxin (FDA, 2023). Additionally, these agents can promote opsonization, facilitating the engulfment and destruction of the pathogen by phagocytic cells, or activate the complement cascade to induce direct lysis of the microbial cell (Janeway's Immunobiology, 2017).